Skip to main content
CiDA 2024 Main banner
Back

Robert E. Lee, MD

Retired FDA / CDRH
Grosse Pointe Shores, Michigan, United States

Robert E. Lee, MD is a medical officer who has served on the Vascular and Endovascular Devices Team in the Office of Cardiovascular Devices, Center for Devices & Radiologic Health, US Food and Drug Administration, in Silver Spring, Maryland. The Vascular and Endovascular Devices Team has the responsibility for the premarket reviews and post-market surveillance of aortic endografts, prosthetic vascular grafts, other devices used in open vascular surgery, topical hemostatic agents, venous valve substitutes, and many of the products used to create vascular access for hemodialysis or to treat dysfunctional AV access.

Dr. Lee is a native of Detroit and a graduate of the University of Michigan Medical School. He completed a general surgery residency and a vascular surgery fellowship at Henry Ford Hospital in Detroit. Dr. Lee is certified by the American Board of Surgery in both general surgery and vascular surgery. Prior to joining the FDA, he practiced vascular and endovascular surgery in southeast Michigan for three decades. Dr. Lee is the first ABS certified vascular surgeon to serve as an FDA medical officer at the Center for Devices and Radiologic Health. He will be retiring from FDA on September 30th after a decade of federal service.

Disclosure information not submitted.

Presentation(s):